43.67
price up icon0.88%   0.38
 
loading
Schlusskurs vom Vortag:
$43.29
Offen:
$43.55
24-Stunden-Volumen:
411.20K
Relative Volume:
0.59
Marktkapitalisierung:
$2.38B
Einnahmen:
$1.28B
Nettoeinkommen (Verlust:
$-222.15M
KGV:
-10.68
EPS:
-4.09
Netto-Cashflow:
$145.52M
1W Leistung:
+4.03%
1M Leistung:
-4.80%
6M Leistung:
-9.30%
1J Leistung:
-18.30%
1-Tages-Spanne:
Value
$42.85
$43.95
1-Wochen-Bereich:
Value
$41.98
$44.20
52-Wochen-Spanne:
Value
$32.48
$57.35

Livanova Plc Stock (LIVN) Company Profile

Name
Firmenname
Livanova Plc
Name
Telefon
4402033250662
Name
Adresse
20 EASTBOURNE TERRACE, LONDON
Name
Mitarbeiter
2,900
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
LIVN's Discussions on Twitter

Vergleichen Sie LIVN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
LIVN
Livanova Plc
43.67 2.36B 1.28B -222.15M 145.52M -4.09
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.69B 4.15B 623.10M 6.95

Livanova Plc Stock (LIVN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-20 Hochstufung Wolfe Research Peer Perform → Outperform
2025-02-26 Herabstufung Wolfe Research Outperform → Peer Perform
2024-10-04 Eingeleitet Goldman Buy
2024-09-17 Hochstufung Robert W. Baird Neutral → Outperform
2024-03-20 Bestätigt Needham Buy
2024-02-20 Hochstufung Mizuho Neutral → Buy
2023-09-06 Eingeleitet HSBC Securities Hold
2023-07-19 Eingeleitet Robert W. Baird Neutral
2023-04-14 Eingeleitet Mizuho Neutral
2022-12-21 Eingeleitet Barclays Equal Weight
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-02-24 Hochstufung UBS Neutral → Buy
2021-12-03 Eingeleitet Goldman Buy
2021-08-20 Bestätigt Needham Buy
2021-07-20 Hochstufung Needham Hold → Buy
2021-03-03 Herabstufung Berenberg Buy → Hold
2021-01-05 Herabstufung Needham Buy → Hold
2020-09-02 Eingeleitet Robert W. Baird Outperform
2020-06-26 Bestätigt Needham Buy
2019-10-30 Bestätigt Needham Buy
2019-02-28 Bestätigt Needham Buy
2018-11-28 Eingeleitet UBS Neutral
2018-08-02 Bestätigt Needham Buy
2018-06-08 Eingeleitet Stifel Buy
2018-05-31 Bestätigt Needham Buy
2018-02-28 Bestätigt Needham Buy
Alle ansehen

Livanova Plc Aktie (LIVN) Neueste Nachrichten

pulisher
07:24 AM

When is LivaNova PLC stock expected to show significant growthMaximize your portfolio’s earning potential - jammulinksnews.com

07:24 AM
pulisher
Jul 26, 2025

Why LivaNova PLC stock attracts strong analyst attention10x Return With Managed Risk - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

LivaNova’s VNS Therapy Shows Sustained Effectiveness in Drug-Resistant Epilepsy - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

Will LivaNova PLC stock benefit from interest rate changesFree Risk Assessment Services - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

How CPBI stock compares to its top competitorsIs LivaNova PLC stock undervalued or overvalued nowMarket-beating performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about LivaNova PLC stockMarket-leading capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is LivaNova PLC a good long term investmentHigh-impact stock picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

External Pacemakers Market Set to Witness Significant Growth - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives LivaNova PLC stock priceBreakthrough financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

LivaNova PLC Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Cardiac Autonomic Control Market Growth in Future Scope - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

In-Line Blood Monitoring Devices Market is projected to grow - openPR.com

Jul 22, 2025
pulisher
Jul 21, 2025

Wearable Cardioverter Defibrillators Market is projected - openPR.com

Jul 21, 2025
pulisher
Jul 19, 2025

Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Neuro Modulation Devices Market is expected to reach US$ 7.6 - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

(LIVN) Technical Data - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

‘A vicious life loop’: Epilepsy community calls for action to address the burden of disease - medianet.com.au

Jul 16, 2025
pulisher
Jul 16, 2025

Principal Financial Group Inc. Purchases 3,668 Shares of LivaNova PLC (NASDAQ:LIVN) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

How LivaNova PLC stock performs during market volatilityStable Stocks With High Yield - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Vagus Nerve Stimulators Market Exclusive Report with Detailed - openPR.com

Jul 10, 2025
pulisher
Jul 09, 2025

LivaNova to Announce Second-Quarter 2025 Results | LIVN Stock Ne - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

LivaNova to Announce Second-Quarter 2025 Results - Business Wire

Jul 09, 2025

Finanzdaten der Livanova Plc-Aktie (LIVN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Livanova Plc-Aktie (LIVN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Bianchi Francesco
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
10,938
SCHERMERHORN TODD C
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
9,473
KOZY WILLIAM A
Director
Jun 15 '25
Option Exercise
0.00
4,840
0
33,148
Barry James Christopher
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
4,772
Story Brooke
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
6,892
Enxing Seng Stacy
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
12,161
WILVER PETER M
Director
Jun 15 '25
Option Exercise
0.00
3,416
0
7,148
Tezel Ahmet
Chief Innovation Officer
Jun 15 '25
Option Exercise
0.00
2,967
0
2,967
Bolton Stephanie
President, Global Epilepsy
Mar 30 '25
Option Exercise
0.00
6,024
0
15,586
Makatsaria Vladimir
Chief Executive Officer
Mar 30 '25
Option Exercise
0.00
9,330
0
9,330
$290.22
price up icon 1.27%
medical_devices STE
$230.46
price up icon 1.41%
medical_devices PHG
$26.16
price up icon 1.24%
$88.99
price up icon 2.59%
$77.61
price up icon 1.09%
medical_devices EW
$80.00
price up icon 5.54%
Kapitalisierung:     |  Volumen (24h):